A detailed history of Rise Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Rise Advisors, LLC holds 250 shares of TEVA stock, worth $4,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 490 48.98%
Holding current value
$4,270
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$15.81 - $18.96 $3,794 - $4,550
-240 Reduced 48.98%
250 $4,000
Q2 2023

Jul 10, 2023

SELL
$7.2 - $9.47 $2,160 - $2,841
-300 Reduced 37.97%
490 $3,000
Q4 2021

Feb 24, 2022

BUY
$7.9 - $10.19 $6,241 - $8,050
790 New
790 $6.33 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.